Pharmaceutical composition effective against biofilms

US8841341B2 · kind B2 · utility

Assignee

• Helmholtz-Zentrum Für Infektionsforschung GmbH · DE

Inventors

• Brigitte Kunze · Braunschweig, DE
• Irene Wagner-Dobler · Evessen, DE
• Herbert Irschik · Wittmund, DE
• Heinrich Steinmetz · Wennigsen (Deister), DE
• Dietmar Schummer · Langen, DE

Key dates

• Filing date: Sep 5, 2008
• Grant date: Sep 23, 2014
• Expiry date: Aug 4, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides a compound termed Carolacton having the structure and derivatives thereof for medical use against biofilm formation by bacteria.